Pricing Log in Create free account

GridAI Technologies Corp. (GRDX) vs INmune Bio, Inc. (INMB)

GridAI Technologies Corp. and INmune Bio, Inc. are both Biotechnology companies. GridAI Technologies Corp. and INmune Bio, Inc. are of similar size ($33.3M and $32.6M). Across the 11 metrics below, INmune Bio, Inc. leads on 6 and GridAI Technologies Corp. on 5.

Valuation

Metric GRDX INMB Biotechnology median
P/E n/m n/m 10.60
P/S n/m 221.67 9.40
P/B 2.07 1.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 121.37 9.02
Earnings yield (113.82%) (59.82%) (32.88%)
Free cash flow yield (26.34%) (54.91%) (23.13%)

Profitability

Metric GRDX INMB Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (485.88%) (74.82%) (51.96%)
Return on assets (34.14%) (57.08%) (46.06%)
Return on invested capital (79.29%) (646.94%) 0.00%

Growth

Metric GRDX INMB Biotechnology median
Revenue growth (TTM) — (51.61%) 6.76%
EPS growth (last fiscal year) 74.65% 11.85% 29.88%
Revenue growth, 5-year CAGR — 35.37% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRDX INMB Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 0.16 4.04 4.97
Net debt to EBITDA 0.10 0.52 1.01

Dividend

Metric GRDX INMB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GRDX INMB Biotechnology median
Market cap 33.30m 32.61m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack